We also associated NP severity scores with indicators of CM disease severity including cerebrospinal (CSF) glucose, protein, and white blood cell levels; days from symptom presentation to diagnosis; and the axonal damage marker, neurofilament light chain (NFL), measured in CSF as well as neuroimaging findings of gliosis and ventriculomegaly. This evidence concerns the gene NEFL and Ventriculomegaly.